Published by Josh White on 29th October 2024
(Sharecast News) - Shield Therapeutics reported a strong third-quarter performance for its iron deficiency treatment Accrufer in the US on Tuesday, achieving net revenue of $7.2m.
URL: http://www.digitallook.com/dl/news/story/34655653/...